{"product_id":"make-better-decisions-finding-and-evaluating-generic-and-branded-drug-market-entry-opportunities-paperback","title":"Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eYali Friedman\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003cem\u003eMake Better Decisions\u003c\/em\u003e helps generic and branded companies alike find and evaluate drug market entry opportunities.Billions of dollars can change hands when key drug patents expire and generics launch. Brands can experience precipitous revenue erosion as generic drugs rapidly gain market share. All the while patients, physicians, payers, pharmacists, and other healthcare stakeholders must race to keep up.\u003cem\u003eMake Better Decisions\u003c\/em\u003e answers the following questions to help you adapt: \u003c\/p\u003e \u003cul\u003e \u003cli\u003eWhen will key drug patents expire?\u003c\/li\u003e \u003cli\u003eHow can I write stronger patents?\u003c\/li\u003e \u003cli\u003eHow can I defeat drug patents?\u003c\/li\u003e \u003cli\u003eHow can I find, evaluate, and plan for generic market entry opportunities?\u003c\/li\u003e \u003cli\u003eHow can I find proprietary out-of-court settlements and deal terms?\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eComprehensive and actionable coverage of commercial, legal, and regulatory factors builds a solid foundation for strategic thinking. Diverse case studies build on this groundwork by analyzing and explaining real-work examples to form the underpinning for your tactical plans.Author Yali Friedman, Ph.D. has more than 20 years experience providing business intelligence to life science companies. He was recently named one of the 100 most influential people in biotechnology by \u003cem\u003eScientific American\u003c\/em\u003e. He is also author of the MBA-level textbook \u003cem\u003eBuilding Biotechnology\u003c\/em\u003e and publisher of the \u003cem\u003eJournal of Commercial Biotechnology\u003c\/em\u003e.\u003c\/p\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 160\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.34 x 8.5 x 5.5 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eIllustrated:\u003c\/strong\u003e Yes\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e July 01, 2019\u003c\/div\u003e\n            ","brand":"BooksCloud","offers":[{"title":"Default Title","offer_id":48099126837507,"sku":"9781934899397","price":72756.0,"currency_code":"KRW","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0588\/9310\/7359\/files\/o2MIu4NJXf9781934899397.webp?v=1778485848","url":"https:\/\/annizon.com\/en-kr\/products\/make-better-decisions-finding-and-evaluating-generic-and-branded-drug-market-entry-opportunities-paperback","provider":"annizon.com","version":"1.0","type":"link"}